An Air France flight traveling from Paris to Detroit was diverted to Montreal on Wednesday after U.S. authorities imposed entry restrictions tied to the Ebola outbreak across multiple African nations. The incident involved a passenger originating from the Democratic Republic of Congo (DRC), according to U.S. Customs and Border Protection.
A CBP spokesperson told CBS News that the airline had boarded the passenger “in error” on a flight bound for the United States, noting the individual “should not have boarded the plane” due to entry restrictions designed to mitigate Ebola transmission risks. The spokesperson confirmed no specific timeframe for the person’s last presence in the DRC was disclosed.
Air France stated the flight diversion occurred “at the request of U.S. authorities,” emphasizing there was “no medical emergency on board.” The Federal Aviation Administration directed CBS News to CBP when contacted about the incident, while the U.S. Centers for Disease Control and Prevention has not yet provided public comment on the matter.
Flight tracking data shows Air France Flight 378 landed at Montreal-Trudeau International Airport at 5:15 p.m. ET on Wednesday. The CDC recently announced a temporary entry ban for foreign travelers who have been in DRC, Uganda, or South Sudan within the past 21 days—a restriction set to last 30 days. This measure follows CDC assessment of Ebola outbreak conditions and aims to address potential introduction of the virus into the United States while allowing time for public health response planning.
According to CDC data, the Bundibugyo virus strain causing the outbreak is not susceptible to vaccines or antibodies developed against the more common Ebola strain. It carries a fatality rate ranging from 25% to 50%, with treatment limited to supportive care. The World Health Organization reported Wednesday that while the risk of global spread remains low, national and regional levels in Congo and Uganda present significant threats, citing nearly 600 suspected cases and 139 suspected deaths. WHO Director-General Tedros Adhanom Ghebreyesus noted those figures are expected to rise.